David Hoffman
Impact in
-
- Growth Hormone and Insulin-like Growth Factors
- Pituitary Gland Disorders and Treatments
- Hormonal and reproductive studies
- Menopause: Health Impacts and Treatments
- Hematology top 10%
- Acute Myeloid Leukemia Research
Papers in
-
- Growth Hormone and Insulin-like Growth Factors 19
- Pituitary Gland Disorders and Treatments 3
- Genetics 4
- Chronic Lymphocytic Leukemia Research 3
- Co-authors
- Ken K. Y. Ho (19 shared papers)Anthony O’Sullivan (7 shared papers)J. Freund (2 shared papers)K C Leung (3 shared papers)Anne T. Reutens (2 shared papers)John J. Kelly (2 shared papers)Mark William Duncan (2 shared papers)Tuan V. Nguyen (2 shared papers)
- Journals
- The Journal of Clinical Endocrinology & Metabolism (9 papers)Cancer Chemotherapy and Pharmacology (4 papers)Annals of Oncology (3 papers)Clinical Pharmacokinetics (2 papers)Future Oncology (2 papers)
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
David Hoffman
46 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 75
- Endocrinology, Diabetes and Metabolism 1.3k
- Hematology 115
- Endocrine and Autonomic Systems 43
- Oncology 156
- Genetics 36
Countries citing papers authored by David Hoffman
This map shows the geographic impact of David Hoffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hoffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hoffman more than expected).
Fields of papers citing papers by David Hoffman
This network shows the impact of papers produced by David Hoffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hoffman. The network helps show where David Hoffman may publish in the future.
Co-authors
The 25 scholars most cited alongside David Hoffman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 381 | |
| 2 | 1994 | 305 | |
| 3 | 1994 | 104 | |
| 4 | 1995 | 103 | |
| 5 | 2001 | 101 | |
| 6 | 2019 | 97 | |
| 7 | 1996 | 88 | |
| 8 | 1995 | 76 | |
| 9 | 1996 | 75 | |
| 10 | 2022 | 60 | |
| 11 | 2020 | 59 | |
| 12 | 2018 | 53 | |
| 13 | 2014 | 45 | |
| 14 | 1995 | 38 | |
| 15 | 1996 | 38 | |
| 16 | 1998 | 37 | |
| 17 | 2000 | 28 | |
| 18 | 1995 | 27 | |
| 19 | 1998 | 26 | |
| 20 | 2016 | 25 |
About David Hoffman
David Hoffman is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics, Pharmacology, Pulmonary and Respiratory Medicine and Oncology, having authored 48 papers that have together received 2k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (19 papers), Lung Cancer Treatments and Mutations (4 papers), Cardiac electrophysiology and arrhythmias (4 papers), Acute Myeloid Leukemia Research (3 papers), Pituitary Gland Disorders and Treatments (3 papers), Pharmaceutical studies and practices (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Renal cell carcinoma treatment (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.3k citations), Hematology (115 citations), Endocrine and Autonomic Systems (43 citations), Oncology (156 citations) and Genetics (36 citations). David Hoffman has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Ken K. Y. Ho, Anthony O’Sullivan, J. Freund, K C Leung, Anne T. Reutens, John J. Kelly, Mark William Duncan, Tuan V. Nguyen, Anne Margot Umpleby and Robert A. Figlin. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer Chemotherapy and Pharmacology, Annals of Oncology, Clinical Pharmacokinetics and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.